PATENT CLAIM ANALYSIS

Application Number: 15877470
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "415000"]

Abstract:
The present invention relates to a composition having improved or enhanced fidelity and/or longevity of the fragrance profile, comprising fragrance materials in a diamond construction and at least one substantially non-odorous fragrance modulator. The invention also relates to methods of use of the compositions for perfuming suitable substrates, including hard surfaces and body parts, particularly skin and hair.

Claim (Index 11):
The composition according to  claim 1 , wherein the substantially non-odorous fragrance modulator is selected from the group consisting of:\n (a) Methyl Glucoside Polyol; Ethyl Glucoside Polyol; Propyl Glucoside Polyol; and their mixtures; (b) Isocetyl Alcohol; (c) PPG-3 Myristyl Ether; Neopentyl Glycol Diethylhexanoate; and their mixtures; (d) Sucrose Laurate, Sucrose Dilaurate, Sucrose Myristate, Sucrose Palmitate, Sucrose Stearate, Sucrose Distearate, Sucrose Tristearate, and their mixtures; (e) Trimethylcyclohexane derivatives having the formula (I): wherein:\n n is 0, 1 or 2; \n A is C\u2550O or CH\u2014OH; \n R 1a  is hydrogen or methyl; \n R 2a  is a C 2 -C 10  hydrocarbon group; and \n ------ is a saturated or unsaturated carbon-carbon bond; \n (f) L-menthoxy ether derivatives having the formula (II): wherein:\n m is 0, 1 or 2; \n B is hydrogen or OH; and \n C is hydrogen or methyl; \n (g) Tetra-hydronaphthalene derivatives having the formula (III): wherein:\n R 1b  is hydrogen or methyl; and \n R 2b  is alkyl; \n (h) Hyaluronic acid disaccharide sodium salt, sodium hyaluronate and their mixtures; (i) Ether derivatives having the formula (IV) or formula (V):\n C 5 H l O m \u2014(OR 1c ) n \u2003\u2003 (IV) \n \n wherein:\n C 5 H l O m  is a pentose residue, wherein l is an integer from 6 to 9, and m is an integer from 1 to 4; \n n is an integer from 1 to 4; and \n R 1c  is C 4 -C 20  hydrocarbon group; and\n C 6 H x O y \u2014(OR 1d ) z \u2003\u2003 (V) \n \n \n \n wherein:\n C 6 H x O y  is a hexose residue, wherein x is an integer from 7 to 11, and y is an integer from 1 to 5; \n z is an integer from 1 to 5; and \n R 1d  is C 4 -C 20  hydrocarbon group; and \n \n (j) Diethylene Glycol Ether derivatives having the formula (VI) or formula (VII):\n C 5 H c O d \u2014(OCH 2 CH 2 \u2014O\u2014CH 2 CH 2 \u2014O\u2014R 1e ) e \u2003\u2003 (VI) \n \n wherein:\n C 5 H c O d  is a pentose residue, wherein c is an integer from 6 to 8, and d is an integer from 1 to 3; \n e is an integer from 2 to 4; and \n R 1e  is C 1 -C 6  alkyl group; and\n C 6 H f O g \u2014(OCH 2 CH 2 \u2014O\u2014CH 2 CH 2 \u2014O\u2014R 1f ) h \u2003\u2003 (VII) \n \n \n \n wherein:\n C 6 H f O g  is a hexose residue, wherein f is an integer from 7 to 10, and g is an integer from 1 to 4; \n h is an integer from 2 to 5; and \n R 1f  is C 1 -C 6  alkyl group; \n \n (k) Hydroquinone Glycoside derivatives having the formula (VIII): wherein:\n R 1g  is selected from the group consisting of: (i) pentose residue, hexose residue, aminosaccharide residue, uronic acid residue and their mixtures; (ii) methylated versions of group (i); and (iii) mixtures of groups (i) and (ii); and \n (l) Propylene Glycol Propyl Ether; Dicetyl Ether; Polyglycerin-4 Ethers; Isoceteth-5; Isoceteth-7, Isoceteth-10; Isoceteth-12; Isoceteth-15; Isoceteth-20; Isoceteth-25; Isoceteth-30; Disodium Lauroamphodipropionate; Hexaethylene glycol monododecyl ether; and their mixtures; (m) Neopentyl Glycol Diisononanoate; Cetearyl Ethylhexanoate; and their mixtures; (n) Glyceryl Ether derivatives having the formula (IX): wherein:\n R 1h  is C 4 -C 12  aliphatic hydrocarbon group; \n (o) Panthenol Ethyl Ether, DL-Panthenol and their mixtures; (p) Aliphatic Dibasic Acid Diester derivatives having the formula (X):\n R 1i OCO R2i COOR 3i \u2003\u2003 (X) \n \n wherein:\n R 1i  is C 4 -C 5  alkyl; \n R 2i  is C 4  alkylene; and \n R 3i  is C 4 -C 5  alkyl; and \n \n (q) Aliphatic Ether derivatives having the formula (XI):\n R 4i \u2014O\u2014(CH(CH 3 )\u2014CH 2 O) a \u2014(CH 2 \u2014CH 2 O) b \u2014H\u2003\u2003 (XI) \n \n wherein:\n a and b are integers such that the sum of a and b is from 1 to 4; and \n R 4i  is an aliphatic chain comprising from 8 to 18 carbons; \n \n (r) N-hexadecyl n-nonanoate, Noctadecyl n-nonanoate and their mixtures; (s) Tricyclodecane Amide derivatives selected from the group consisting of:\n (i) the compounds of formula (XII): \n wherein:\n X is selected from: \n t is 1 to 8; Y is hydrogen, \u2003or a halogen; and each R 1j  is independently selected from a hydrogen, or C 1 -C 4  alkyl; (ii) the compounds of formula (XIII): wherein:\n each R 2j  is independently selected from a hydrogen, methyl, ethyl or C 3 -C 18  alkyl, cycloalkyl or cycloheteroalkyl, with the proviso that both R 2e  groups are not hydrogen; and \n (iii) mixtures of the compounds of formulae (XII) and (XIII); and (t) mixtures thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.3125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15175865', '15175781', '14567192', '13701884', '14354016']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671175260871191
- 35 USC 102 Novelty (BERT): 0.6388293921390309
- Combined Prediction Score: 0.7542887126923103
- Mean Citation Score: 440.535646
- Max Citation Score: 662.1891
- Similarity Product: 533.7030183169485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test